Greenwich LifeSciences, Inc. (GLSI) Ownership

NASDAQ: GLSITop holders, insider trades and short interest.

GLSI ownership summary

as of October 18, 2026
Institutions
12.3%
of shares outstanding
Insiders
47.91%
of shares outstanding
Shares outstanding
14.7M
Float
7.6M
shares available to trade
Short interest
20.66%
1.6M shares short
Days to cover
13.74
short interest down 3.1% vs prior month
  • Institutions 12.26%
  • Insiders 47.91%
  • Other investors 39.82%

GLSI top institutional holders

20 largest
Greenwich LifeSciences, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1BlackRock Inc3.31%486K$7.1M+51,994 (+12.0%)June 30, 2026
2Vanguard Capital Management, LLC1.90%278K$4.0M−20,076 (−6.7%)June 30, 2026
3Geode Capital Management, LLC1.15%168K$2.4M+12,713 (+8.2%)June 30, 2026
4State Street Corp0.97%143K$2.1M+9,211 (+6.9%)June 30, 2026
5Vanguard Portfolio Management, LLC0.55%81K$1.2M+21,950 (+37.3%)June 30, 2026
6Northern Trust Corp0.55%80K$1.2M+5,103 (+6.8%)June 30, 2026
7Bank of New York Mellon Corp0.33%48K$696,945+1,377 (+3.0%)June 30, 2026
8Vanguard Fiduciary Trust Co0.31%46K$668,791+1,057 (+2.4%)June 30, 2026
9Morgan Stanley - Brokerage Accounts0.30%43K$632,154+13,620 (+45.7%)June 30, 2026
10The Goldman Sachs Group Inc0.27%39K$572,237−192 (−0.5%)June 30, 2026
11Jane Street Group LLC0.19%28K$402,948+27,694 (0.0%)June 30, 2026
12UBS Group AG0.16%23K$340,601+2,293 (+10.9%)June 30, 2026
13State Of Wisconsin Investment Board0.15%23K$329,397+2,300 (+11.3%)June 30, 2026
14GSA Capital Partners LLP0.13%20K$284,351+19,543 (0.0%)June 30, 2026
15Massachusetts Financial Services Company0.12%18K$260,765+17,922 (0.0%)June 30, 2026
16STRS OHIO0.12%18K$258,990+4,100 (+29.9%)June 30, 2026
17Charles Schwab Investment Management Inc0.12%17K$248,776+495 (+3.0%)June 30, 2026
18Vanguard Global Advisers, LLC0.08%12K$172,723+1,536 (+14.9%)June 30, 2026
19Ancora Advisors LLC0.07%11K$156,267−26,760 (−71.4%)June 30, 2026
20Stifel Financial Corp0.07%10K$145,835+10,023 (0.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 17 holders added 203K shares and 3 cut 47K.

GLSI top mutual fund and ETF holders

19 largest
Greenwich LifeSciences, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1iShares Russell 2000 ETF1.37%201K$2.9M−2,304 (−1.1%)September 30, 2026
2Vanguard MStar Total Stk Mkt Idx Invest1.36%199K$2.9M—August 31, 2026
3Fidelity Small Cap Index0.51%74K$1.1M+680 (+0.9%)July 31, 2026
4iShares Russell 2000 Growth ETF0.50%73K$1.1M−92 (−0.1%)September 30, 2026
5Vanguard Russell 2000 ETF0.26%39K$562,052+720 (+1.9%)August 31, 2026
6Vanguard US Momentum Factor ETF0.23%34K$498,672+13,177 (+62.5%)June 30, 2026
7Fidelity Extended Market Index0.23%33K$485,752+3,181 (+10.5%)August 31, 2026
8iShares Micro-Cap ETF0.17%25K$360,505−171 (−0.7%)September 30, 2026
9Ancora/Thelen Small-Mid Cap I0.14%20K$291,000+20,000 (0.0%)September 30, 2026
10Stt Strt SPDR® Russell2000 US SmCapETF0.13%19K$270,164+896 (+5.1%)August 31, 2026
11Schwab Small Cap Index0.11%16K$235,870—August 31, 2026
12Fidelity Total Market Index0.08%12K$179,183—August 31, 2026
13iShares Russell 2000 Small-Cap Idx Instl0.08%12K$170,322—August 31, 2026
14MFS Blended Research Small Cap Eq R60.08%11K$166,728−123 (−1.1%)August 31, 2026
15Fidelity Series Total Market Index0.07%9,629$140,102—August 31, 2026
16Vanguard Global Momentum Factor ETF CAD0.07%9,565$139,171+2,838 (+42.2%)June 30, 2026
17Fidelity Nasdaq Composite Index0.06%8,961$130,383—August 31, 2026
18Nuveen Small Cap Blend Idx R60.06%8,122$118,175—August 31, 2026
19Vanguard Russell 2000 Growth ETF0.05%7,500$109,125+36 (+0.5%)August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

GLSI insider transactions

latest 8
Greenwich LifeSciences, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-01-13Snehal PatelBuy$29.831,800$53,694
2026-01-12Snehal PatelBuy$27.542,900$79,866
2025-12-31Snehal PatelBuy$21.364,300$91,848
2025-12-30Snehal PatelBuy$21.732,900$63,017
2025-12-18Snehal PatelBuy$12.624,100$51,742
2025-11-25Snehal PatelBuy$8.374,600$38,502
2025-11-07Snehal PatelBuy$8.4310,600$89,358
2025-10-31Snehal PatelBuy$9.262,300$21,298

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

GLSI shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns GLSI

Institutional investors own 12.3% of Greenwich LifeSciences's shares and insiders 47.91%. The largest holder is BlackRock Inc with 3.31% of the shares (486K), as of June 30, 2026. Among the top 20 institutions, 17 added shares and 3 reduced their stake in the latest filings. Short interest is 20.66% of the float, or 13.74 days of average trading volume. The share count rose 20.6% since 2018.

Related: GLSI analyst forecast, GLSI key metrics. See the GLSI stock overview for the latest quote and news.

GLSI ownership FAQ

Who owns the most Greenwich LifeSciences stock?

The largest shareholders of Greenwich LifeSciences are BlackRock Inc (3.31%), Vanguard Capital Management, LLC (1.90%), Geode Capital Management, LLC (1.15%), State Street Corp (0.97%), Vanguard Portfolio Management, LLC (0.55%).

What percentage of Greenwich LifeSciences is owned by institutions?

Institutions hold 12.3% of Greenwich LifeSciences's shares outstanding; insiders hold 47.91%.

Which funds own Greenwich LifeSciences?

The largest fund holders of Greenwich LifeSciences are iShares Russell 2000 ETF (1.37%), Vanguard MStar Total Stk Mkt Idx Invest (1.36%), Fidelity Small Cap Index (0.51%), iShares Russell 2000 Growth ETF (0.50%), Vanguard Russell 2000 ETF (0.26%).

What is Greenwich LifeSciences's short interest?

1.6M shares of Greenwich LifeSciences were sold short, 20.66% of the float; at the average daily volume it would take 13.74 days to cover.

Are insiders buying or selling Greenwich LifeSciences?

Of the latest 8 reported insider transactions in Greenwich LifeSciences (since October 31, 2025), 8 were purchases and 0 were sales.

How many shares of Greenwich LifeSciences are outstanding?

Greenwich LifeSciences has 14.7M shares outstanding, of which 7.6M are in the public float.

Biotechnology: ownership